Sunshine Biopharma (SBFM) Inventory (2019 - 2026)

Sunshine Biopharma's Inventory history runs 8 years deep, the most recent figure standing at $13.2 million for Q1 2026.

• Quarterly Inventory rose 11.06% year-over-year to $13.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.2 million (up 11.06% YoY) and the FY2025 annual result came in at $13.5 million, up 19.45% from the prior year.
• Inventory was $13.2 million for Q1 2026 at Sunshine Biopharma, down from $13.5 million in the prior quarter.
• Across five years, Inventory topped out at $14.1 million in Q3 2025 and bottomed at $181496.0 in Q1 2022.
• A 5-year average of $7.4 million and a median of $7.7 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2022 — Inventory soared 3014.0% — and 2026, when it gained 11.06%.
• Sunshine Biopharma's Inventory stood at $3.3 million in 2022, then soared by 74.31% to $5.7 million in 2023, then surged by 96.66% to $11.3 million in 2024, then rose by 19.45% to $13.5 million in 2025, then declined by 2.25% to $13.2 million in 2026.
• Business Quant data shows SBFM's Inventory at $13.2 million in Q1 2026, $13.5 million in Q4 2025, and $14.1 million in Q3 2025.